Quick Takeaways
- Iwicki Mark T. has 7 issuer positions tracked on this page.
- Estimated disclosed ownership value: $879,119.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Iwicki Mark T.
- Location
- Marlborough, MA
- Summary
- The estimated net worth of Iwicki Mark T. is at least $879,119 dollars as of 07 Jan 2026. Iwicki Mark T. is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $342.7K. Iwicki Mark T. is the Director of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $212.3K. Iwicki Mark T. is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $204.6K. Iwicki Mark T. is the Director of Merus N.V. and owns shares of Merus N.V. stock worth about $119.6K.
- Signature
- /s/ Mark Iwicki
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Iwicki Mark T. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Q32 Bio Inc. ($342,666).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Iwicki Mark T.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | Director | $342,666 | 23 Oct 2025 | ||
| KALA | KALA BIO, Inc. | Director | $212,257 | -$93,679 | -31% | 23 Oct 2025 |
| JBIO | Aerovate Therapeutics, Inc. | Director | $204,625 | 05 Jun 2024 | ||
| MRUS | Merus N.V. | Director | $119,571 | 12 Dec 2025 | ||
| AKRO | Akero Therapeutics, Inc. | Director | $0 | 09 Dec 2025 | ||
| THRD | Third Harmonic Bio, Inc. | Director | $0 | 11 Aug 2025 | ||
| IKT | Inhibikase Therapeutics, Inc. | Chief Executive Officer, Director | 05 Jan 2026 |
Insider Transactions Reported by Iwicki Mark T.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.